Загрузка...

Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis

Patients with rheumatoid arthritis (RA) are at increased risk of cardiovascular disease. Dyslipidemia is a known adverse effect of tocilizumab (TCZ), an anti-interleukin-6 receptor antibody used in RA treatment. We aimed to assess the effect of TCZ on lipid profile and adipokine levels in RA patient...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Mol Sci
Главные авторы: Hoffman, Elinoar, Rahat, Michal A., Feld, Joy, Elias, Muna, Rosner, Itzhak, Kaly, Lisa, Lavie, Idit, Gazitt, Tal, Zisman, Devy
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6770905/
https://ncbi.nlm.nih.gov/pubmed/31540528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20184633
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!